# Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

> **NCT00002403** · PHASE1 · COMPLETED · sponsor: **Aronex Pharmaceuticals** · enrollment: 12 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Zintevir

## Key facts

- **NCT ID:** NCT00002403
- **Lead sponsor:** Aronex Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 12 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002403, "Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*